[PRESS RELEASE] – PORTLAND, Ore., Aug. 7, 2025 – Grön (pronounced grewn), one of America’s fastest-growing medical marijuana brands, announced its official launch in the Pennsylvania medical cannabis market.
This expansion marks a major milestone in Grön’s East Coast growth strategy and a commitment to supporting medical marijuana patients in need of accessible, effective relief.
“Over the past two years, we’ve seen incredible momentum across the East Coast,” Grön founder and CEO Christine Apple said. “Expanding into Pennsylvania’s thriving medical program allows us to reach more patients seeking targeted cannabinoid effects for sleep, stress and daily wellness, and we’re proud to offer products that deliver both relief and great taste.”
Pennsylvania patients will now have access to Grön Pearl Troches, precisely dosed, full-spectrum troches that are gluten-free and made with natural fruit flavors. As Grön expands its product offerings in the state, patients can expect new flavors and higher-dose options designed to meet a wide range of tastes, preferences and needs.
Each Grön troche is thoughtfully formulated with targeted cannabinoid ratios to support specific effects. Current offerings include:
- Blueberry Lemon 1:3 Sativa (10mg THC / 30mg CBG Per Pearl Troche)
- Tangelo 2:1:1 Sativa (10mg THC / 5mg CBC / 5 mg CBG Per Pearl Troche)
- Pomegranate 1:4 Hybrid (10mg THC / 40mg CBD Per Pearl Troche)
- Blackberry Lemon 1:1:1 Indica (10mg THC / 10mg CBD / 10mg CBN Per Pearl Troche)
- Tart Cherry 1:10 Indica (2.5 mg THC / 25 mg CBN Per Pearl Troche)
To explore availability and find a location, visit: https://eatgron.com/pennsylvania-medical-marijuana-infused-troches/
